- Home
- CVM vs PRZO Comparison
CVM vs PRZO Comparison
Compare CVM & PRZO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CVM | PRZO |
|---|---|---|
| Founded | 1983 | 2014 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 21.4M | 18.6M |
| IPO Year | 1996 | 2022 |
Fundamental Metrics
Financial Performance| Metric | CVM | PRZO |
|---|---|---|
| Price | $1.25 | $0.60 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 616.7K | ★ 5.4M |
| Earning Date | 05-13-2026 | 03-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $264,033.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 65.45 | N/A |
| 52 Week Low | $0.89 | $0.45 |
| 52 Week High | $13.48 | $2.15 |
Technical Indicators
Market Signals| Indicator | CVM | PRZO |
|---|---|---|
| Relative Strength Index (RSI) | 32.22 | 45.06 |
| Support Level | $0.89 | $0.45 |
| Resistance Level | $1.59 | $0.82 |
| Average True Range (ATR) | 0.11 | 0.13 |
| MACD | 0.06 | -0.00 |
| Stochastic Oscillator | 8.33 | 18.98 |
Price Performance
Historical ComparisonAbout CVM Cel-Sci Corporation
CEL-SCI Corp is a late clinical-stage biotechnology company dedicated to research and development directed at improving the treatment of cancer and other diseases by using the immune system, the body's natural defense system. The company is focused on the development of the following product candidates and technologies: 1) Multikine, an investigational Phase 3 immunotherapy under development for the potential treatment of certain head and neck cancers; 2) LEAPS (Ligand Epitope Antigen Presentation System) technology, for the potential treatment of rheumatoid arthritis.
About PRZO ParaZero Technologies Ltd.
ParaZero Technologies Ltd operates as an aerospace defense company focused on the development of smart, autonomous solutions for the manned and unmanned aerial systems (UAS) industry. The Company develops, manufactures, markets, and sells counter-UAS net-launching platforms designed to protect against hostile drones in both battlefield and urban environments, precision aerial delivery systems for military applications, and smart, autonomous parachute safety systems designed to enable safe flight operations over populated areas and beyond visual line-of-sight. The Company sells its products internationally.